Chung Min-Shen, Chuang Yao-Chi, Lee Jong-Jer, Lee Wei-Chia, Chancellor Michael B, Liu Rue-Tsuan
Division of Metabolism, Chang Gung Memorial Hospital, Kaohsiung Medical Center, Chang Gung University College of Medicine, 123 Ta-Pei Road, Niao-Sung District, Kaohsiung, 833, Taiwan.
Int Urol Nephrol. 2014 Jul;46(7):1269-75. doi: 10.1007/s11255-014-0669-2. Epub 2014 Mar 5.
To evaluate the correlates of nocturia and subsequent mortality in patients with type 2 diabetes mellitus (T2DM).
A self-administered questionnaire containing overactive bladder symptom score was obtained from subjects with T2DM. Nocturia and severe nocturia were defined as rising ≥2 or ≥3 per night to void, respectively. Patient characteristics and diabetes-related complications to risk of nocturia were evaluated.
Of 1,301 consecutive subjects, 59.6 and 25.3% reported having nocturia and severe nocturia, respectively. The presence and severity of nocturia increased with age and overactive bladder (OAB). The presence of OAB was 28.8% in patients with nocturia and was significantly associated with nocturia (OR 2.26) after adjustment for age and duration of DM. The presence of stroke, calcium channel blocker use, hypertension, waist circumference greater than standard, albuminuria, and higher serum creatinine level, and high-sensitivity C-reactive protein was associated with nocturia and severe nocturia after adjustment for age, duration of DM, and the presence of OAB. Higher estimated glomerular filtration rate, hemoglobin, serum albumin, and male gender were less likely to have nocturia (OR <1). Severe nocturia increased mortality (OR 1.93) independent of age and DM duration and has a higher mortality rate compared to those without severe nocturia (6.1 vs. 2.4%, P = 0.001) in 2.5 years follow-up.
While OAB is an important predictor of nocturia in T2DM patients, systemic issues, including stroke, hypertension, obesity, and chronic kidney disease, have further impact on nocturia independent of OAB. Severe nocturia is a marker for increased mortality.
评估2型糖尿病(T2DM)患者夜尿症及其后续死亡率的相关因素。
从T2DM患者中获取一份包含膀胱过度活动症症状评分的自填问卷。夜尿症和严重夜尿症分别定义为每晚起身排尿≥2次或≥3次。评估患者特征及糖尿病相关并发症与夜尿症风险的关系。
在1301名连续入选的受试者中,分别有59.6%和25.3%的人报告有夜尿症和严重夜尿症。夜尿症的存在及严重程度随年龄和膀胱过度活动症(OAB)而增加。夜尿症患者中OAB的发生率为28.8%,在调整年龄和糖尿病病程后,OAB与夜尿症显著相关(比值比[OR]为2.26)。在调整年龄、糖尿病病程和OAB的存在情况后,中风、使用钙通道阻滞剂、高血压、腰围大于标准值、蛋白尿、较高的血清肌酐水平以及高敏C反应蛋白与夜尿症和严重夜尿症相关。较高的估计肾小球滤过率、血红蛋白、血清白蛋白以及男性性别患夜尿症的可能性较小(OR<1)。严重夜尿症与死亡率增加相关(OR为1.93),独立于年龄和糖尿病病程,在2.5年的随访中,严重夜尿症患者的死亡率高于无严重夜尿症患者(6.1%对2.4%,P=0.001)。
虽然OAB是T2DM患者夜尿症的重要预测因素,但包括中风、高血压、肥胖和慢性肾脏病在内的全身性问题在独立于OAB的情况下对夜尿症有进一步影响。严重夜尿症是死亡率增加的一个标志。